qozito.wordpress.com
Genzyme (NASDAQ: GENZ) found a virux strain and stopped production of two drugs atthe Mass., facility. The strain, Vesivirus apparently does not causde human infection but interrupts the growth of cellsd that are used tomake drugs. Aldurazymed — a treatment for MPS I, a rare and fatapl disease caused by an enzyme deficiency was last filled at the Genzyme facility inSeptembere 2008, according to BioMarin BMRN). The company has about 10 monthes of vialed inventory on it said, and uses a seconr fill finish supplier. A third supplier is expected to be qualifies laterthis year, BioMarin BioMarin makes the bulk material used in Aldurazyme at its Novato facility.
The Food and Drug Administratiom hadinspected Genzyme’s plant in September and Octobe r and reportedly was concerned aboutt controls to protect against contamination.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment